Collaboration will support clinical decision-making for patients with suspected ischemic strokes
Brainomix has integrated its E-ASPECTS solution to assist in stroke diagnosis and treatment with Wellbeing Software's vendor-neutral AI Connect platform
Connected healthcare specialist, Wellbeing Software, is working with stroke imaging company, Brainomix, to accelerate the introduction of AI and deep learning to assist clinical decision-making for ischemic stroke patients.
When a patient is admitted to hospital with a suspected ischemic stroke, they undergo a CT scan to confirm, or rule out, a diagnosis.
Patients are then assessed to receive treatment such as thrombolysis, endovascular treatment or, for severe cases, decompressive craniectomy.
These treatments are time-sensitive and decisions must be made within the first few hours to ensure the best-possible outcome.
By applying AI and deep learning, clinicians are able to make informed decisions regarding treatment, reducing the chances of further brain damage or mortalities
Brainomix’s E-ASPECTS solution is designed to assist healthcare professionals to make faster, more-informed decisions by applying Artificial Intelligence (AI) when assessing ischemic stroke damage.
It interprets scans based on metrics drawn from more than 150,000 images, sourced across 27 countries including theUK, Germany, Spain, Italy and the United States.
The platform is able to quantify the volume of ischemia against the ASPECTS score and provide a standardised stroke diagnosis quickly.
Brainomix is the latest provider to integrate its technology through Wellbeing Software’s AI Connect platform, which enables hospitals to embed their chosen algorithms into radiology workflow, no matter what RIS or PACS they are running.
Riaz Rahman, vice president of healthcare global at Brainomix, said: “Early intervention is key to improve recovery following an ischemic stroke.
“By applying AI and deep learning, clinicians are able to make informed decisions regarding treatment, reducing the chances of further brain damage or mortalities.”
Working with innovative companies like Brainomix represents a real opportunity for the NHS to access transformative AI technology and to embed it quickly and easily into their everyday workflow
Wellbeing research found that 85% of respondents acknowledged the benefits of AI integration within RIS workflow, including its ability to support work management and report prioritisation, especially the notification of critical findings.
Chris Yeowart, director at Wellbeing Software, said: “Working with innovative companies like Brainomix represents a real opportunity for the NHS to access transformative AI technology and to embed it quickly and easily into their everyday workflow through our vendor-neutral gateway.”